ChengDu ShengNuo Biotec Co.,Ltd. (SHA:688117)
26.60
-0.30 (-1.12%)
Aug 20, 2026, 3:00 PM CST
ChengDu ShengNuo Biotec Revenue
ChengDu ShengNuo Biotec had revenue of 262.98M CNY in the quarter ending June 30, 2026, with 71.62% growth. This brings the company's revenue in the last twelve months to 911.15M, up 53.21% year-over-year. In the year 2025, ChengDu ShengNuo Biotec had annual revenue of 741.46M with 62.57% growth.
Revenue (ttm)
911.15M
Revenue Growth
+53.21%
P/S Ratio
6.43
Revenue / Employee
567.69K
Employees
1,605
Market Cap
5.86B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 741.46M | 285.39M | 62.57% |
| Dec 31, 2024 | 456.07M | 21.05M | 4.84% |
| Dec 31, 2023 | 435.02M | 39.30M | 9.93% |
| Dec 31, 2022 | 395.72M | 9.19M | 2.38% |
| Dec 31, 2021 | 386.53M | 7.76M | 2.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Guizhou Xinbang Pharmaceutical | 5.44B |
| Hunan Jiudian Pharmaceutical | 3.01B |
| Guizhou Bailing Group Pharmaceutical | 2.93B |
| Shandong Wit Dyne Health | 2.02B |
| Hunan Warrant Pharmaceutical Co.,Ltd | 1.49B |
| Jinghua Pharmaceutical Group | 1.48B |
| Bide Pharmatech | 1.35B |
| Wanbangde Pharmaceutical Holding Group | 1.18B |